Which of the following drugs causes activation of K+-ATP channels?

Correct Answer: A. Nicorandil

Nicorandil is a unique hybrid vasodilator that combines two distinct mechanisms: it is both a K+-ATP channel opener (potassium channel activator) AND a nitrate (organic nitrate with NO-donor activity). This dual action distinguishes it from pure nitrates. The K+-ATP channel activation causes hyperpolarization of vascular smooth muscle cells, leading to vasodilation independent of the nitrate pathway. This mechanism is particularly valuable in angina management because it provides vasodilation through a non-nitrate mechanism, reducing the risk of nitrate tolerance—a major clinical problem with long-term nitrate use in India where patients often self-medicate with nitrates. Nicorandil's K+-ATP channel opening also provides cardioprotection through preconditioning-like effects, making it especially useful in acute coronary syndromes. The drug is metabolized hepatically and has a half-life of ~1 hour, allowing twice-daily dosing (5–20 mg BD). In Indian clinical practice, nicorandil is preferred for chronic angina management precisely because its dual mechanism avoids the tolerance issue seen with pure nitrates alone.

Why the other options are wrong

B. Nitroglycerin — Nitroglycerin is a pure organic nitrate that works exclusively via NO-mediated vasodilation; it does NOT activate K+-ATP channels. It causes vasodilation by releasing nitric oxide, which activates guanylate cyclase and increases cGMP. While effective for acute angina relief, it lacks the K+-ATP channel mechanism and is prone to tolerance with continuous use—a key clinical distinction from nicorandil. C. Isosorbide dinitrate — Isosorbide dinitrate is another pure organic nitrate (like nitroglycerin) that operates solely through NO-mediated vasodilation without K+-ATP channel activation. It is a long-acting nitrate used for chronic angina prophylaxis but suffers from the same tolerance problem as other pure nitrates. The NBE trap here is confusing long-acting nitrates with K+-ATP activators based on their antianginal efficacy. D. Molsidomine — Molsidomine is a non-nitrate NO donor (sydnonimine class) that releases NO through a different pathway than organic nitrates, but it does NOT activate K+-ATP channels. While it provides vasodilation via NO-mediated mechanisms and avoids some tolerance issues, it lacks the potassium channel opening property that defines nicorandil's unique dual mechanism.

High-Yield Facts

Mnemonics

NIKO = Nicorandil Is K-channel Opener Nicorandil is the ONLY antianginal that opens K-ATP channels. All others (GTN, ISDN, molsidomine) are pure NO donors. Use this when you see 'K-channel' in the stem. Dual = No Tolerance Nicorandil's dual action (K-channel + nitrate) prevents tolerance; pure nitrates alone → tolerance. Remember: dual mechanism = clinical advantage in long-term use.

NBE Trap

NBE pairs nicorandil with other antianginal drugs to test whether students confuse mechanism with clinical efficacy. All four options treat angina, but only nicorandil has K+-ATP channel activation—a mechanistic distinction, not a clinical one. Students may incorrectly choose a pure nitrate if they focus on "antianginal effect" rather than "mechanism of action."

Clinical Pearl

In Indian outpatient practice, nicorandil is often preferred over long-acting nitrates (ISDN) for chronic angina prophylaxis because patients frequently default to continuous nitrate use without nitrate-free intervals, leading to tolerance. Nicorandil's K+-ATP mechanism provides an escape route from this tolerance problem, making it a pragmatic choice in resource-limited settings where patient compliance with dosing schedules is variable.

_Reference: KD Tripathi Pharmacology Ch. 31 (CVS Drugs); Harrison Principles of Internal Medicine Ch. 243 (Ischemic Heart Disease)_